Hudson CEO appointed to NHMRC Council
Wednesday, 27 October, 2021
Director and CEO Professor Elizabeth Hartland has been appointed to the Council of the .
Professor Hartland will join 12 other leading medical researchers, academics, clinicians and administrators on the Council. Her 3-year term begins immediately, and she joins a distinguished group entrusted with the responsibility of guiding Australians鈥 current and future health.
鈥淭his is clearly a crucial time for the medical sector,鈥 Professor Hartland said.
鈥淚t has never been more important to ensure that Australians have access to authoritative, evidence-based health advice.鈥
Professor Hartland is an international leader in the field of microbiology and immunology who brings a wealth of experience to the role beyond her specialty area of microbial drug resistance.
She has held a Royal Society/NHMRC Howard Florey Fellowship in the Department of Biochemistry, Imperial College London and Lecturer/Senior Lecturer positions at Monash University.
As well as her role at Hudson Institute, which she has held since 2017, Professor Hartland is Head of the Department of Molecular and Translational Science at Monash University.
鈥淎s the nation鈥檚 leading expert body in health and medical research, the NHMRC has a proud history of serving and protecting Australians; I look forward to the opportunity to play a part in that vital work,鈥 she said.
RACP urges swift action after NSW healthcare funding report
RACP is calling for swift action to address doctor burnout and invest in preventive health care...
Butler's priorities: Medicare, PBS, aged care reform, NDIS's future
Following his cabinet ministry appointment as Minister for Health and Ageing and Minister...
Ahpra: Review recommendations "in lock step" with reform agenda
The Australian Health Practitioner Regulation Agency said it supports, in principle, the reform...